Back to Research Library
Laboratory Protocols 10 min read

The Complete Beginner's Peptide Guide

Everything you need before your first peptide cycle — reconstitution cheat sheet, safety mistakes, what to buy, and the peptide cheat sheet for beginners.

Peptides Categorised by Research Goal

Fat metabolism: Semaglutide, Tirzepatide, AOD-9604. GLP-1 class agonists suppress caloric intake and support fat oxidation pathways.

Connective tissue repair: BPC-157, TB-500. Research demonstrates accelerated tendon, ligament, and soft tissue recovery relative to controls.

Sleep architecture: DSIP, Epitalon. Documented modulation of slow-wave sleep biology without producing next-day sedative effects.

Skin and ageing biology: GHK-Cu, Epitalon. Stimulate collagen synthesis, support skin elasticity, and engage telomere biology.

Cognitive and stress biology: Selank, Semax. Lower cortisol response markers and support cognitive function research without stimulant mechanisms.

Sexual and hormonal signalling: PT-141, Kisspeptin. Act on central nervous system receptor pathways rather than peripheral vascular mechanisms alone.

Growth hormone axis: CJC-1295, Ipamorelin, MK-677. Amplify natural pulsatile GH release for body composition and recovery research.

Immune modulation: Thymosin Alpha-1, LL-37. Regulate immune response and antimicrobial defence mechanisms.

What Must Be in Place Before Beginning a Peptide Research Protocol

Bacteriostatic water: The required diluent for lyophilised peptides. Standard water lacks the preservative properties needed to maintain sterility over the duration of use. Keeps reconstituted solutions protected from microbial growth for weeks.

Appropriate syringes: 29 or 31 gauge, 1mL insulin-type syringes. Designed for subcutaneous administration. Fine-gauge needles minimise discomfort at the administration site. Widely available from pharmacies.

Alcohol preparation swabs: Applied to both the vial septum and the administration site before each use. This step is not optional — skipping it is the primary route through which contamination occurs.

A compound with independent third-party verification: A Certificate of Analysis from an accredited external laboratory confirming purity above 98%. Suppliers who cannot provide this documentation should not be used.

A written protocol: Research quantity, administration frequency, and total cycle duration should be defined before starting. Established BPC-157 research protocols typically use 250–500mcg per administration over 4–8 week cycles.

Reconstitution Reference Table

| Peptide Quantity | BAC Water Volume | Resulting Concentration | |---|---|---| | 5mg | 1ml | 500 mcg per 10 units | | 5mg | 2ml | 250 mcg per 10 units | | 10mg | 2ml | 500 mcg per 10 units | | 10mg | 5ml | 200 mcg per 10 units | | 20mg | 2ml | 1000 mcg per 10 units |

The 5mg / 2ml ratio is the most practical for precise smaller measurements. The 20mg / 2ml ratio produces a high-concentration solution — verify calculations carefully before drawing.

Critical Errors That Undermine Research Validity

Purchasing from unverified sources. Counterfeit and underdosed peptides are common in unregulated markets. Low pricing relative to verified suppliers is the most reliable indicator of compromised product quality.

Starting at full research quantities. Biological response varies substantially between individuals. Beginning at lower quantities allows observation of early response patterns before committing to full protocol amounts.

Reusing injection equipment. Sterile single-use needles are non-negotiable. Reuse introduces contamination risk that cannot be mitigated by any other precaution.

Using unverified bacteriostatic water. The quality and sterility of the diluent is as important as the quality of the compound itself. Verify the source and check the expiry date before every use.

Proceeding without a COA. The Certificate of Analysis from a third-party accredited laboratory is the only reliable evidence that a compound meets stated purity specifications. The absence of this document should end the transaction.

Improper post-reconstitution storage. Peptides reconstituted and left at ambient temperature degrade rapidly. Refrigeration is required immediately following reconstitution.

No defined research timeline. Open-ended administration without a defined protocol endpoint is methodologically poor practice and wastes compound. Define the cycle before beginning.

Sleep-Relevant Peptides

DSIP. The name is itself the description — Delta Sleep Inducing Peptide. Research documents direct modulation of slow-wave sleep architecture. Among the most underappreciated research tools in this category.

Epithalon. Evidence suggests it resets pineal gland melatonin output toward younger secretion patterns. Over 40 years of published research. The only peptide with documented human longevity outcome data.

Selank. Modulates the balance between cortisol-driven arousal and GABAergic inhibition. Research shows sleep onset improvement without the sedative-hangover profile of pharmaceutical sleep aids.

CJC-1295 and Ipamorelin together. Growth hormone secretion peaks naturally during slow-wave sleep phases. Administration timed to precede sleep amplifies this pulse. The body's own biology is supported rather than overridden.

BPC-157. A substantial proportion of poor sleep quality originates from gastrointestinal inflammation signalling through the gut-brain axis. BPC-157 research addresses this source.

Cognitive Performance Peptides

Semax: A synthetic ACTH fragment. Elevates BDNF (brain-derived neurotrophic factor) production in the prefrontal cortex. Research documents improved working memory and recall speed.

Selank: A tuftsin analogue. Modulates GABA and serotonin receptor systems without sedation. Reduces anxiety markers while maintaining alertness.

Dihexa: Seven orders of magnitude more potent than BDNF in promoting new synaptic connection formation. Originally developed within an Alzheimer's research programme.

PE-22-28: Derived from the Selank sequence. Upregulates serotonin receptor density. Research links this to improved mood stability and sustained attentional performance.

Epithalon: Activates telomerase in pineal tissue. The resulting improvement in circadian rhythm quality has measurable downstream effects on cognitive clarity and processing speed.

Compounds With Established Research Records That Remain Clinically Unavailable

Thymosin Alpha-1: Carries pharmaceutical approval in more than 35 countries as an immune modulator. Used in the management of hepatitis B and C globally. Not approved within the United States regulatory system.

Selank: Prescribed within Russian clinical medicine as a registered anxiolytic compound since 2009. Modulates GABA without producing dependence or sedation. Has no equivalent within US pharmaceutical approval frameworks.

DSIP: Over 40 years of sleep disorder research behind it. Directly modulates slow-wave sleep architecture. No pharmaceutical entity has progressed it through the US FDA approval process.

Epitalon: The only compound with documented reactivation of telomerase in human cell cultures. Originated from research at the St. Petersburg Institute of Bioregulation and Gerontology. No US clinical trials have been conducted.

Dihexa: Research at Washington State University established it to be many orders of magnitude more potent than endogenous BDNF at forming new neural connections. No human trial funding has been secured despite this remarkable preclinical profile.


All content is for research and educational purposes only. Consult a qualified professional before beginning any research protocol.

Research Use Only: All products are sold strictly for in-vitro laboratory research purposes. Not for human or veterinary consumption. Not approved by the MHRA for any therapeutic use. Not intended to diagnose, treat, cure, or prevent any disease. Purchaser must be 18+ and a qualified researcher.

King Pharma

King Pharma is a UK-based supplier of independently verified, laboratory-grade peptide research compounds. All products are supplied for qualified scientific research use only.

⚠️ None of our products are intended for human use. No medicinal claims are made or implied.

© 2026 King Pharma Ltd. All rights reserved. Registered in England & Wales.

Secure payments:
VISAMCAMEXMaestro